Filing Details

Accession Number:
0001161697-10-000198
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-05 12:00:00
Reporting Period:
2010-03-03
Filing Date:
2010-03-05
Accepted Time:
2010-03-05 16:41:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceutical Partners Inc. CPRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1257729 J Milton Wallace 355 Alhambra Circle
Suite 1370
Coral Gables FL 33134
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2010-03-03 1,400 $0.67 351,400 No 4 P Direct
Common Stock, Par Value $0.001 Per Share Acquisiton 2010-03-04 22,500 $0.69 373,900 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share 29,184 Indirect .
Footnotes
  1. Securities are owned through the Reporting Person's Individual Retirement Accounts.
  2. Of the securities acquired, 3,900 are owned beneficially with the Reporting Person's spouse, Patricia Wallace, and 18,600 are owned through the Reporting Person's Individual Retirement Accounts.
  3. Following this acquisition, the Reporting Person directly owns beneficially: (i) 323,900 shares with his wife, Patricia Wallace and (ii) 50,000 shares through his Individual Retirement Accounts. Reporting Person also reports beneficial ownership of 29,184 shares of the Company's common stock that are owned of record by Biscayne National Corp. (Reporting Person is the President of Biscayne National Corp.) While Reporting Person owns the shares held by Biscayne National Corp. for Section 13(d) purposes, he disclaims beneficial ownership of such shares for Section 16(b) purposes except to the extent of his pecuniary interest in such shares.